ALIMP Stock Overview
A medical technology company, manufactures and sells implants for orthopedic surgery. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Implanet S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.13 |
| 52 Week High | €0.17 |
| 52 Week Low | €0.035 |
| Beta | 1.18 |
| 11 Month Change | -1.92% |
| 3 Month Change | 17.51% |
| 1 Year Change | 165.07% |
| 33 Year Change | -67.72% |
| 5 Year Change | -95.70% |
| Change since IPO | -99.96% |
Recent News & Updates
Shareholder Returns
| ALIMP | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | -1.9% | 2.7% | -0.3% |
| 1Y | 165.1% | 26.7% | -3.5% |
Return vs Industry: ALIMP exceeded the French Medical Equipment industry which returned 28.4% over the past year.
Return vs Market: ALIMP exceeded the French Market which returned -2.5% over the past year.
Price Volatility
| ALIMP volatility | |
|---|---|
| ALIMP Average Weekly Movement | 7.9% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALIMP's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALIMP's weekly volatility has decreased from 25% to 8% over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 43 | Ludovic Lastennet | www.implanet.com |
Implanet S.A., a medical technology company, manufactures and sells implants for orthopedic surgery. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation.
Implanet S.A. Fundamentals Summary
| ALIMP fundamental statistics | |
|---|---|
| Market cap | €15.93m |
| Earnings (TTM) | -€6.91m |
| Revenue (TTM) | €7.30m |
2.2x
P/S Ratio-2.3x
P/E RatioIs ALIMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALIMP income statement (TTM) | |
|---|---|
| Revenue | €7.30m |
| Cost of Revenue | €4.11m |
| Gross Profit | €3.19m |
| Other Expenses | €10.09m |
| Earnings | -€6.91m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.055 |
| Gross Margin | 43.67% |
| Net Profit Margin | -94.65% |
| Debt/Equity Ratio | 116.8% |
How did ALIMP perform over the long term?
See historical performance and comparison